Leaflet DAROB 160mg tablets
Indicated for: cardiac arrhythmias
Route of administration: oral
Substance: sotalol (beta blocker)
ATC: C07AA07 (Cardiovascular system | Beta blocking agents | Beta blocking agents, non-selective)
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Older people may have an increased risk of side effects.
This medicine may increase the risk of heart rhythm disturbances.
Sotalol is an antiarrhythmic medication used for the treatment of cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia. It works by blocking potassium channels and beta-adrenergic receptors, stabilizing the heart rhythm.
The medication is taken orally, as directed by a doctor, usually two or three times daily. It is important for patients to follow the prescribed dosage and undergo regular check-ups to monitor cardiac function.
Patients should be aware of potential side effects, such as dizziness, fatigue, or bradycardia. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, fatigue, and bradycardia. In rare cases, severe reactions such as torsades de pointes or heart failure may occur. Patients should be informed of these risks before starting treatment.
General data about DAROB 160mg
- Substance: sotalol
- Date of latest medicines list: 01-07-2013
- Product code: W05549002
- Concentration: 160mg
- Pharmaceutical form: tablets
- Quantity: 50
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for sotalol
- 160mg
- 80mg